Tag: Endocrine disruptor

In 1971, the U.S. Food and Drug Administration (FDA) issued a bulletin advising physicians to stop prescribing diethylstilbestrol (DES) to pregnant women. This pivotal moment was a direct response to mounting evidence that the synthetic estrogen, once thought to prevent miscarriage, was causing serious health problems in the children of women who took it.

Between 1938 and 1971, diethylstilbestrol (DES) was prescribed to millions of pregnant women before it was discovered to be ineffective and harmful. This in-utero exposure, particularly if a female fetus is exposed to diethylstilbestrol, has led to a range of significant and lifelong health issues for the women, now known as 'DES Daughters'.

In 2016, the FDA banned triclosan from consumer antiseptic wash products after manufacturers failed to prove it was both safe for daily use and more effective than plain soap and water. Understanding the side effects of triclosan soap is crucial for making informed choices about personal care products.

Between 1940 and 1971, the synthetic estrogen known as diethylstilbestrol (DES), or Stilbestrol, was widely prescribed to pregnant women in the mistaken belief that it prevented miscarriages. This article examines the historical and medical context of what is Stilbestrol used for, its wide-ranging applications, and the devastating long-term health consequences that led to its ban.

While polysiloxanes are widely used in thousands of products due to their inertness and stability, recent scientific evidence questions the generalized assumption of their non-toxicity, pointing to specific health concerns based on their molecular structure and application. A crucial area of research is understanding exactly what are the side effects of polysiloxanes, particularly in long-term human contact through medical implants, cosmetics, and drug delivery systems.